These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 27782867

  • 1. Predictive significance of CCL21 and CXCL13 levels in the minor salivary glands of patients with Sjögren's syndrome.
    Lee KE, Kang JH, Yim YR, Kim JE, Lee JW, Wen L, Park DJ, Kim TJ, Park YW, Yoon KC, Lee JS, Lee SS.
    Clin Exp Rheumatol; 2017; 35(2):234-240. PubMed ID: 27782867
    [Abstract] [Full Text] [Related]

  • 2. Serum, but Not Saliva, CXCL13 Levels Associate With Infiltrating CXCL13+ Cells in the Minor Salivary Gland Lesions and Other Histologic Parameters in Patients With Sjögren's Syndrome.
    Chatzis L, Goules AV, Stergiou IE, Voulgarelis M, Tzioufas AG, Kapsogeorgou EK.
    Front Immunol; 2021; 12():705079. PubMed ID: 34484201
    [Abstract] [Full Text] [Related]

  • 3. The Significance of Ectopic Germinal Centers in the Minor Salivary Gland of Patients with Sjögren's Syndrome.
    Lee KE, Kang JH, Yim YR, Kim JE, Lee JW, Wen L, Park DJ, Kim TJ, Park YW, Yoon KC, Lee JS, Lee SS.
    J Korean Med Sci; 2016 Feb; 31(2):190-5. PubMed ID: 26839471
    [Abstract] [Full Text] [Related]

  • 4. Anti-centromere antibody-positive Sjögren's syndrome: A distinct clinical subgroup?
    Lee KE, Kang JH, Lee JW, Wen L, Park DJ, Kim TJ, Park YW, Lee SS.
    Int J Rheum Dis; 2015 Sep; 18(7):776-82. PubMed ID: 26179502
    [Abstract] [Full Text] [Related]

  • 5. Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome.
    Amft N, Curnow SJ, Scheel-Toellner D, Devadas A, Oates J, Crocker J, Hamburger J, Ainsworth J, Mathews J, Salmon M, Bowman SJ, Buckley CD.
    Arthritis Rheum; 2001 Nov; 44(11):2633-41. PubMed ID: 11710719
    [Abstract] [Full Text] [Related]

  • 6. CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren's syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization.
    Barone F, Bombardieri M, Rosado MM, Morgan PR, Challacombe SJ, De Vita S, Carsetti R, Spencer J, Valesini G, Pitzalis C.
    J Immunol; 2008 Apr 01; 180(7):5130-40. PubMed ID: 18354239
    [Abstract] [Full Text] [Related]

  • 7. Is minor salivary gland biopsy more than a diagnostic tool in primary Sjögren׳s syndrome? Association between clinical, histopathological, and molecular features: a retrospective study.
    Carubbi F, Alunno A, Cipriani P, Di Benedetto P, Ruscitti P, Berardicurti O, Bartoloni E, Bistoni O, Caterbi S, Ciccia F, Triolo G, Gerli R, Giacomelli R.
    Semin Arthritis Rheum; 2014 Dec 01; 44(3):314-24. PubMed ID: 24935529
    [Abstract] [Full Text] [Related]

  • 8. Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndrome.
    Barone F, Bombardieri M, Manzo A, Blades MC, Morgan PR, Challacombe SJ, Valesini G, Pitzalis C.
    Arthritis Rheum; 2005 Jun 01; 52(6):1773-84. PubMed ID: 15934082
    [Abstract] [Full Text] [Related]

  • 9. Association of plasmacytoid dendritic cells with B cell infiltration in minor salivary glands in patients with Sjögren's syndrome.
    Zhao J, Kubo S, Nakayamada S, Shimajiri S, Zhang X, Yamaoka K, Tanaka Y.
    Mod Rheumatol; 2016 Sep 01; 26(5):716-24. PubMed ID: 26706891
    [Abstract] [Full Text] [Related]

  • 10. Chemokine saliva levels in patients with primary Sjögren's syndrome, associated Sjögren's syndrome, pre-clinical Sjögren's syndrome and systemic autoimmune diseases.
    Hernández-Molina G, Michel-Peregrina M, Hernández-Ramírez DF, Sánchez-Guerrero J, Llorente L.
    Rheumatology (Oxford); 2011 Jul 01; 50(7):1288-92. PubMed ID: 21330342
    [Abstract] [Full Text] [Related]

  • 11. Detection of HTLV-1 in the labial salivary glands of patients with Sjögren’s syndrome: a distinct clinical subgroup?
    Lee SJ, Lee JS, Shin MG, Tanaka Y, Park DJ, Kim TJ, Park YW, Lee SS.
    J Rheumatol; 2012 Apr 01; 39(4):809-15. PubMed ID: 22382336
    [Abstract] [Full Text] [Related]

  • 12. Laser microdissection coupled with RNA-seq reveal cell-type and disease-specific markers in the salivary gland of Sjögren's syndrome patients.
    Tandon M, Perez P, Burbelo PD, Calkins C, Alevizos I.
    Clin Exp Rheumatol; 2017 Apr 01; 35(5):777-785. PubMed ID: 28421997
    [Abstract] [Full Text] [Related]

  • 13. Elastographic ultrasound: an additional image tool in Sjögren's syndrome.
    Kimura-Hayama E, Criales-Vera S, Azpeitia-Espinosa L, Pacheco-Molina C, Reyes E, Lima G, Hernandez-Ramirez D, Llorente L, Hernandez-Molina G.
    Int J Rheum Dis; 2018 Jun 01; 21(6):1293-1300. PubMed ID: 29624878
    [Abstract] [Full Text] [Related]

  • 14. [Abnormal interferon-inducible protein-10 expression in the labial glands of patients with Sjogren's syndrome].
    Zhou W, Dong Y, Zhao Y, Tang FL.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct 01; 25(5):603-7. PubMed ID: 14650168
    [Abstract] [Full Text] [Related]

  • 15. CXCL13 and CCL11 Serum Levels and Lymphoma and Disease Activity in Primary Sjögren's Syndrome.
    Nocturne G, Seror R, Fogel O, Belkhir R, Boudaoud S, Saraux A, Larroche C, Le Guern V, Gottenberg JE, Mariette X.
    Arthritis Rheumatol; 2015 Dec 01; 67(12):3226-33. PubMed ID: 26359802
    [Abstract] [Full Text] [Related]

  • 16. Increased extracellular levels of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in minor salivary glands of patients with Sjögren's syndrome.
    Ek M, Popovic K, Harris HE, Nauclér CS, Wahren-Herlenius M.
    Arthritis Rheum; 2006 Jul 01; 54(7):2289-94. PubMed ID: 16802368
    [Abstract] [Full Text] [Related]

  • 17. Thymosin β4 and β10 in Sjögren's syndrome: saliva proteomics and minor salivary glands expression.
    Bosello S, Peluso G, Iavarone F, Tolusso B, Messana I, Faa G, Castagnola M, Ferraccioli G.
    Arthritis Res Ther; 2016 Oct 06; 18(1):229. PubMed ID: 27716395
    [Abstract] [Full Text] [Related]

  • 18. The prognostic value of routinely performed minor salivary gland assessments in primary Sjögren's syndrome.
    Risselada AP, Kruize AA, Goldschmeding R, Lafeber FP, Bijlsma JW, van Roon JA.
    Ann Rheum Dis; 2014 Aug 06; 73(8):1537-40. PubMed ID: 24525912
    [Abstract] [Full Text] [Related]

  • 19. Diminished CXCR5 expression in peripheral blood of patients with Sjögren's syndrome may relate to both genotype and salivary gland homing.
    Aqrawi LA, Ivanchenko M, Björk A, Ramírez Sepúlveda JI, Imgenberg-Kreuz J, Kvarnström M, Haselmayer P, Jensen JL, Nordmark G, Chemin K, Skarstein K, Wahren-Herlenius M.
    Clin Exp Immunol; 2018 Jun 06; 192(3):259-270. PubMed ID: 29453859
    [Abstract] [Full Text] [Related]

  • 20. Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome.
    Fava RA, Kennedy SM, Wood SG, Bolstad AI, Bienkowska J, Papandile A, Kelly JA, Mavragani CP, Gatumu M, Skarstein K, Browning JL.
    Arthritis Res Ther; 2011 Jun 06; 13(6):R182. PubMed ID: 22044682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.